StockTipsArenaBeta

BUY Sun Pharmaceutical Industries Ltd. — Somil Mehta, Sharekhan

BUYSun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries share price target & all analyst calls

bySomil Mehta, SharekhanHorizon: 1 year1 Sept 2026via NDTV Profit

Entry₹1,936.1Inferred
Target₹2,100
Total upside +8.47% (call closed)
Stop loss₹1,868-3.52% risk
Exit₹1,8689 Sept 2026, 12:09 pm
Stop-loss hit-3.52%
Follow Somil Mehta for new callsGet alertsWatch SUNPHARMA for new buy/sell callsGet alertsSee 15 active Long-term calls on SUNPHARMASee 211 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 9 Sept 2026
10 supporting3 neutral3 opposing
Supports the BUY call (10)

10 other SEBI-registered advisors have active long-term BUY calls on this stock, with 2 issued in the last 14 days

Advisor consensus · same horizon·2 Sept · 6d ago

Sun Pharma participated in a White House ceremony, announcing agreements with the U.S. government to prioritize access to affordable medicines. The company committed to Most Favored Nation (MFN) prici

BSE · Company Update·1 Sept · 1w ago

(opens in new tab)

Sun Pharma and its subsidiaries have won an antitrust litigation in the US related to the Lipitor patent settlement. The US Court of Appeals affirmed a summary judgment in their favor, denying class c

BSE · Company Update·17 Aug · 3w ago

(opens in new tab)

4 advisors have active short-term BUY calls on this stock

Advisor consensus · adjacent horizon·30 Jul · 1mo ago

Neutral / worth noting (3)

Sun Pharmaceutical Industries Ltd has been assigned international issuer credit ratings by Moody's Ratings (Baa1, Stable Outlook) and S&P Global Ratings (BBB+, Stable Outlook). These ratings are inves

BSE · Company Update·8 Sept · today

(opens in new tab)
Weighs against the BUY call (3)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Sun Pharmaceutical Industries

All analyst calls on Sun Pharmaceutical Industries

More from Somil Mehta, Sharekhan

Every call and its outcome